# Neurogene Inc. (NGNE)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NGNE/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -30.93M | $ -26.40M | $ 9.13M | $ 237.78M |
| 2025 | $ 0 | $ -92.51M | $ -79.62M | $ 9.89M | $ 264.89M |
| 2024 | $ 972.2K | $ -78.98M | $ -75.06M | $ 12.43M | $ 310.38M |
| 2023 | $ 0 | $ -39.27M | $ -69.12M | $ 16.26M | $ 186.02M |
| 2022 | $ 0 | $ -63.71M | $ -50.77M | $ 4.69M | $ 98.63M |
| 2021 | $ 0 | $ -72.14M | $ -60.08M | $ 12.98M | $ 142.86M |
| 2020 | $ 0 | $ -42.39M | $ -35.14M | $ 12.12M | $ 191.22M |
| 2019 | $ 0 | $ -89.63M | $ -17.56M | $ 1.21M | $ 141.69M |
| 2018 | $ 33.02M | $ -41.71M | $ -40.99M | $ 6.0K | $ 72.67M |
| 2017 | $ 0 | $ -67.60M | $ -62.19M | $ 33.0K | $ 98.89M |
| 2016 | $ 0 | $ -26.68M | $ -22.23M | $ 47.0K | $ 144.66M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.04 |
| Liabilities / Eq | 0.11 |
| Current Ratio | 13.08 |

## Other views

- [Metrics](https://sponda.capital/en/NGNE.md)
- [Charts](https://sponda.capital/en/NGNE/charts.md)
- [Compare](https://sponda.capital/en/NGNE/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.